Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02642991 · ClinicalTrials.gov registry record · NA
Dispensing Study for a New Study Lens
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02642991: Completed NA study, sponsored by CooperVision.
NCT02642991 is a NA study that has completed, run by CooperVision. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02642991, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study investigated the performance criteria over one week of daily wear to determine if the comfilcon A asphere lens (test) performed equivalently to the comfilcon A sphere (control) in terms of measurement and subjective ratings of visual performance.
Primary Outcome
Distance visual acuity High Illumination was assessed using logMAR
Interventions
- DEVICE comfilcon A
- DEVICE Phenacite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02642991 record still lists
NCT02642991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which comfilcon A is the first listed.
NCT02642991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02642991 about?
NCT02642991 is a clinical study titled "Dispensing Study for a New Study Lens". This study investigated the performance criteria over one week of daily wear to determine if the comfilcon A asphere lens (test) performed equivalently to the comfilcon A sphere (control) in terms of measurement and subjective ratings of visual performance.
What is the current status of trial NCT02642991?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-11. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02642991?
The interventions under investigation include: comfilcon A (DEVICE), Phenacite (DEVICE).
Who is sponsoring clinical trial NCT02642991?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02642991's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia